New Ipo Stocks To Buy Apr 2026

: Developed through the proprietary Glyph platform, this biotech firm aims to treat depression and anxiety. Scheduled for NASDAQ listing around April 30, 2026 .

: This mid-April biotech listing is up 48.9% from its offer price. Blockbuster Candidates for Later in 2026 new ipo stocks to buy

: A $20 billion market cap asset manager listing on the NYSE. The IPO is bundled with a closed-end fund, Pershing Square USA, Ltd. (PSUS) . : Developed through the proprietary Glyph platform, this